Cargando…
Primary mediastinal synovial sarcomas
Synovial sarcoma is a malignant mesenchymal neoplasm that accounts for approximately 10% of all soft tissue sarcomas. These tumors most commonly occur in the extremities of young adults but are not restricted to this site and can arise in virtually any organ system. Synovial sarcomas originating in...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794274/ https://www.ncbi.nlm.nih.gov/pubmed/35118281 http://dx.doi.org/10.21037/med-20-19 |
_version_ | 1784640792657133568 |
---|---|
author | Syred, Katherine Weissferdt, Annikka |
author_facet | Syred, Katherine Weissferdt, Annikka |
author_sort | Syred, Katherine |
collection | PubMed |
description | Synovial sarcoma is a malignant mesenchymal neoplasm that accounts for approximately 10% of all soft tissue sarcomas. These tumors most commonly occur in the extremities of young adults but are not restricted to this site and can arise in virtually any organ system. Synovial sarcomas originating in the mediastinum are exceptionally rare and are often mistaken for other, more common neoplasms in this location, especially since there are no specific imaging characteristics or clinical manifestations. Contrary to synovial sarcomas of the extremities, mediastinal tumors more commonly affect male patients. Histologically, these tumors can be divided into monophasic, biphasic and poorly differentiated variants, further complicating the diagnostic process. Recent advances in immunohistochemical and molecular techniques have provided useful tools to confirm the diagnosis and distinguish these tumors from other mediastinal neoplasms. The treatment of mediastinal synovial sarcomas often requires multimodal therapy, including surgery, chemotherapy and radiation. Despite this, the prognosis for synovial sarcomas in this location appears to be worse than for their analogues in the soft tissue, likely related to the often large size of the lesions and close proximity to critical anatomic structures making complete surgical resection difficult to achieve. This review summarizes the clinicopathological, immunohistochemical and molecular characteristics of these rare neoplasms. |
format | Online Article Text |
id | pubmed-8794274 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-87942742022-02-02 Primary mediastinal synovial sarcomas Syred, Katherine Weissferdt, Annikka Mediastinum Review Article Synovial sarcoma is a malignant mesenchymal neoplasm that accounts for approximately 10% of all soft tissue sarcomas. These tumors most commonly occur in the extremities of young adults but are not restricted to this site and can arise in virtually any organ system. Synovial sarcomas originating in the mediastinum are exceptionally rare and are often mistaken for other, more common neoplasms in this location, especially since there are no specific imaging characteristics or clinical manifestations. Contrary to synovial sarcomas of the extremities, mediastinal tumors more commonly affect male patients. Histologically, these tumors can be divided into monophasic, biphasic and poorly differentiated variants, further complicating the diagnostic process. Recent advances in immunohistochemical and molecular techniques have provided useful tools to confirm the diagnosis and distinguish these tumors from other mediastinal neoplasms. The treatment of mediastinal synovial sarcomas often requires multimodal therapy, including surgery, chemotherapy and radiation. Despite this, the prognosis for synovial sarcomas in this location appears to be worse than for their analogues in the soft tissue, likely related to the often large size of the lesions and close proximity to critical anatomic structures making complete surgical resection difficult to achieve. This review summarizes the clinicopathological, immunohistochemical and molecular characteristics of these rare neoplasms. AME Publishing Company 2020-06-30 /pmc/articles/PMC8794274/ /pubmed/35118281 http://dx.doi.org/10.21037/med-20-19 Text en 2020 Mediastinum. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. |
spellingShingle | Review Article Syred, Katherine Weissferdt, Annikka Primary mediastinal synovial sarcomas |
title | Primary mediastinal synovial sarcomas |
title_full | Primary mediastinal synovial sarcomas |
title_fullStr | Primary mediastinal synovial sarcomas |
title_full_unstemmed | Primary mediastinal synovial sarcomas |
title_short | Primary mediastinal synovial sarcomas |
title_sort | primary mediastinal synovial sarcomas |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794274/ https://www.ncbi.nlm.nih.gov/pubmed/35118281 http://dx.doi.org/10.21037/med-20-19 |
work_keys_str_mv | AT syredkatherine primarymediastinalsynovialsarcomas AT weissferdtannikka primarymediastinalsynovialsarcomas |